Cost-effectiveness of MRI and PET imaging for the evaluation of axillary lymph node metastases in early stage breast cancer

European Journal of Surgical Oncology

Volumn 37, Issue 1, 2011, Pages 40-46

  Meng, Y ^a   Ward, S ^a   Cooper, K ^a   Harnan, S ^a   Wyld, L ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Axilla; Breast cancer; Cost effectiveness analysis; MRI; PET; Simulation model

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE METASTASIS; BREAST CANCER; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL EVALUATION; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; HEALTH CARE COST; HUMAN; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SIMULATION; UNITED KINGDOM;

AXILLA; BREAST NEOPLASMS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; SENTINEL LYMPH NODE BIOPSY;

EID: 78650297462     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2010.10.001     Document Type: Article

References (29)

1. Office for National Statistics Cancer registration statistics England 2007: MB1 No 38 2010 Office for National Statistics http://www.statistics.gov. uk/StatBase/Product.asp?vlnk=7720&Pos=1&ColRank=1&Rank=272
2. D.K. Blanchard, J.H. Donohue, C. Reynolds, and C.S. Grant Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer Arch Surg 138 5 2003 482 487
3. A.D. Purushotham, S. Upponi, and M.B. Klevesath Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial J Clin Oncol 23 19 2005 4312 4321
4. R.E. Mansel, L. Fallowfield, and M. Kissin Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial J Natl Cancer Inst 98 9 2006 599 609
5. R. Crane-Okada, R.A. Wascher, D. Elashoff, and A.E. Giuliano Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer Ann Surg Oncol 15 7 2008 1996 2005
6. S.A. McLaughlin, M.J. Wright, and K.T. Morris Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements J Clin Oncol 26 32 2008 5213 5219
7. National Institute for Health and Clinical Excellence (NICE) Early and locally advanced breast cancer: diagnosis and treatment 2009 National Collaborating Centre for Cancer
8. Cooper K, Meng Y, Harnan S, Ward S, Fitzgerald P, Papaioannou D et al. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in breast cancer: systematic review and economic evaluation. Health Technol Assess, in press.
9. C.D. Lehman, and M.D. Schnall Imaging in breast cancer: magnetic resonance imaging Breast Cancer Res 7 5 2005 215 219
10. K. Facey, I. Bradbury, G. Laking, and E. Payne Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers Health Technol Assess 11 44 2007 iii iv xi-267
11. H.M. Treasury The green book: appraisal and evaluation in central government 2003
12. H. Mumtaz, M.A. Hall-Craggs, and T. Davidson Staging of symptomatic primary breast cancer with MR imaging AJR Am J Roentgenol 169 2 1997 417 424
13. I.C. Smith, K.N. Ogston, and P. Whitford Staging of the axilla in breast cancer - accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-d-glucose Ann Surg 228 2 1998 220 227
14. K.A. Kvistad, J. Rydland, H.B. Smethurst, S. Lundgren, H.E. Fjosne, and O. Haraldseth Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI Eur Radiol 10 9 2000 1464 1471
15. S. Alvarez, E. Anorbe, P. Alcorta, F. Lopez, I. Alonso, and J. Cortes Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review AJR Am J Roentgenol 186 5 2006 1342 1348
16. T. Kim, A.E. Giuliano, and G.H. Lyman Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis Cancer 106 1 2006 4 16
17. L.G. Wilke, L.M. McCall, and K.E. Posther Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial Ann Surg Oncol 13 4 2006 491 500
18. Department of Health NHS reference costs 2008 2009 Department of Health London
19. Department of Health NHS reference costs 2003 2004 Department of Health London
20. P.V. Pandharipande, M.G. Harisinghani, and E.M. Ozanne Staging MR lymphangiography of the axilla for early breast cancer: cost-effectiveness analysis AJR Am J Roentgenol 191 5 2008 1308 1319
21. J.S. Jeruss, K.K. Hunt, and Y. Xing Is intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer cost effective? Cancer 107 10 2006 2328 2336
22. S. Ward, E. Simpson, S. Davis, D. Hind, A. Rees, and A. Wilkinson Taxanes for the adjuvant treatment of early breast cancer: systematic review and economic evaluation Health Technol Assess 11 40 2007 1 144
23. T.O. Tengs, and A. Wallace One thousand health-related quality-of-life estimates Med Care 38 6 2000 583 637
24. R.K. Orr, N.F. Col, and K.M. Kuntz A cost-effectiveness analysis of axillary node dissection in postmenopausal women with estrogen receptor-positive breast cancer and clinically negative axillary nodes Surgery 126 3 1999 568 576
25. C. Kamby, and L. Sengelov Pattern of dissemination and survival following isolated locoregional recurrence of breast cancer. A prospective study with more than 10 years of follow up Breast Cancer Res Treat 45 2 1997 181 192
26. S.S. Mak, K.F. Mo, J.J. Suen, S.L. Chan, W.L. Ma, and W. Yeo Lymphedema and quality of life in Chinese women after treatment for breast cancer Eur J Oncol Nurs 13 2 2009 110 115
27. R. Ara, and J. Brazier Populating an economic moel with health state utility values: moving towards better practice Value Health 13 5 2010 509 518
28. A. Briggs, M. Sculpher, and K. Claxton Decision modelling for health economic evaluation 2006 Oxford university press
29. C.Q. Liu, Y. Guo, J.Y. Shi, and Y. Sheng Late morbidity associated with a tumour-negative sentinel lymph node biopsy in primary breast cancer patients: a systematic review Eur J Cancer 45 9 2009 1560 1568